- On March 3, 2026, Xometry, Inc. launched an expanded Enterprise Machining Lead Time Prediction Model and upgraded dynamic pricing logic within its Instant Quoting Engine®, aiming to deliver more accurate production timelines, broader rapid-delivery options, and greater sourcing efficiency across its AI-native manufacturing marketplace.
- By feeding real-world production and delivery outcomes back into its algorithms, Xometry is turning each completed order into training data, steadily tightening the link between digital quotes and physical manufacturing performance.
- Next, we’ll examine how Xometry’s upgraded lead time prediction engine could influence its AI-driven marketplace investment narrative and growth thesis.
AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Xometry Investment Narrative Recap
To own Xometry, you need to believe its AI powered marketplace can turn better quoting, faster lead times, and denser network data into improving unit economics despite ongoing losses and heavy investment. The new Enterprise Machining Lead Time Model directly touches the key near term catalyst of efficiency and marketplace growth, but it does not remove the central risk that high technology and operating spend may still outpace revenue and margin progress.
Against this backdrop, the February 24, 2026 guidance for 24 to 25 percent Q1 revenue growth and at least 21 percent full year growth is especially relevant. That outlook was framed before the March 3 release of the upgraded lead time and pricing models, so investors will be watching closely to see whether these AI enhancements reinforce the growth and margin expectations already embedded in management’s targets.
Yet while the upside from these AI upgrades is appealing, investors should also be aware that...
Read the full narrative on Xometry (it's free!)
Xometry's narrative projects $989.6 million revenue and $57.5 million earnings by 2028.
Uncover how Xometry's forecasts yield a $62.33 fair value, a 69% upside to its current price.
Exploring Other Perspectives
The bullish analysts were already assuming revenue could reach about US$1.0 billion by 2028 and earnings near US$34.3 million; against that optimistic backdrop, this new AI release and the risk that large OEMs might increasingly bypass third party platforms highlight how differently you and other investors might view Xometry’s future and how much these narratives could shift as the impact of the new models becomes clearer.
Explore 3 other fair value estimates on Xometry - why the stock might be worth 31% less than the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Xometry research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Xometry research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xometry's overall financial health at a glance.
Curious About Other Options?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Uncover the next big thing with 32 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com